Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Tennessee › Nashville
Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Nashville, TN
Masomo 15 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Nashville na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
InaajiriHatua 2
- Vanderbilt University Medical Center, Nashville
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
InaajiriHatua 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
InaajiriHatua 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
InaajiriHatua 1/2
- SCRI Oncology Partners ( Site 0100), Nashville
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
InaajiriHatua 2
- SCRI Oncology Partners ( Site 7002), Nashville
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
InaajiriHatua 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
InaajiriHatua 1
- SCRI Oncology Partners, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
InaajiriHatua 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
InaajiriHatua 2
- Tennessee Oncology, Nashville
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
InaajiriHatua 1/2
- Sarah Cannon Research Institute, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
InaajiriHatua 1/2
- Vanderbilt University Medical Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
InaajiriHatua 1/2
- TriStar BMT, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
InaajiriHatua 3
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- SCRI Oncology Partners, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
InaajiriHatua 1
- Tennessee Oncology, Nashville
Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine
- New York City, NYUtafiti 21
- Baldwin Park, CAUtafiti 19
- Chicago, ILUtafiti 18
- Houston, TXUtafiti 17
- Los Angeles, CAUtafiti 17
- Boston, MAUtafiti 16
- Milwaukee, WIUtafiti 16
- Portland, ORUtafiti 15
- Philadelphia, PAUtafiti 15
- Durham, NCUtafiti 14
- Dallas, TXUtafiti 13
- Seattle, WAUtafiti 12
Masomo mengine katika Nashville
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 97
- Saratani ya MatitiUtafiti 80
- Saratani ya MetastasiUtafiti 70
- Kansari ya kolorektaliUtafiti 69
- Saratani (aina zote)Utafiti 65
- Kansari ya MayaiUtafiti 49
- Saratani ya ProstateUtafiti 42
- Saratan ya MapafuUtafiti 40
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 39
- Kansari ya PancreasUtafiti 39
- Saratani ya EndometrialUtafiti 38
- MelanomaUtafiti 33
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.